Pegram

623 citations
2 papers · 532 · 1 hit paper · h-index 2

Impact in

  • Oncology top 10%
    • HER2/EGFR in Cancer Research
    • Cytokine Signaling Pathways and Interactions
  • Genetics top 10%
    • Estrogen and related hormone effects

Papers in

Pegram

2 papers receiving 508 citations

Pegram's Hit Papers

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. 1995 · 518 citations
5180+10+20Years since publication100200300400500

Peers

Pegram
Comparison fields: 5 of 53
  • Oncology 330
  • Genetics 228
  • Cancer Research 85
  • Radiology, Nuclear Medicine and Imaging 114
  • Molecular Biology 213
Replace Jacqueline C. Newby with:
Jacqueline C. Newby United Kingdom
J M Knowlden United Kingdom
Carol M. Dutkowski United Kingdom
Christina M.W. Chan United Kingdom
Gabriel Hortobagyi United States
Maddalena T. Tilli United States
M Dowsett United Kingdom
Osborne Ck United States
Mariko Nishio Japan
P. Cannon United Kingdom
Pegram relative to Jacqueline C. Newby United Kingdom Jacqueline C. Newby's profile →
Citations per field
00.5×
Jacqueline C. Newby · 1×
Citations per year

Countries citing papers authored by Pegram

Since Specialization
Citations

This map shows the geographic impact of Pegram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pegram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pegram more than expected).

Fields of papers citing papers by Pegram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pegram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pegram. The network helps show where Pegram may publish in the future.

Co-authors

The 6 scholars most cited alongside Pegram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pegram Line = papers co-authored together Pegram links everyone, so they are left out of the graph.

All Works

2 of 2 papers shown
#Work
1
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Hit paper breakdown →
1995518
2 201014

About Pegram

Pegram is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Infectious Diseases and Organic Chemistry, having authored 2 papers that have together received 532 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (1 paper), Cancer Treatment and Pharmacology (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (330 citations), Genetics (228 citations), Cancer Research (85 citations), Radiology, Nuclear Medicine and Imaging (114 citations) and Molecular Biology (213 citations). Pegram has collaborated with scholars based in United States. Frequent co-authors include Richard J. Pietras, Liliana Ramos, Slamon Dj, Jane Arboleda, Rebecca Lee and Joyce M. Slingerland. Their work appears in journals such as Breast Cancer Targets and Therapy and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact